2 followers
Bringing hope and relief to patients with undertreated rare diseases through the development and commercialization of curative first-in-class gene-modified cell therapies.
Gaurav Shah
Amgen
206 followers
Miami Foundation
2 followers
Immunome
2 followers
Nunzio Marc DeSantis Architects
1 follower
Lucid Management and Capital Partners LP
1 follower
Bristol-Myers Squibb
176 followers
Merkle
63 followers
Publicis Sapient
47 followers
FactSet
36 followers
Univision
37 followers
Viatris
33 followers
Explore companies